Another landmark study called “Hormone Replacement Therapy After Breast Cancer – Is It Safe?,” or HABITS, evaluated the ...

Objective Financial toxicity (FT) poses a major challenge in cancer treatment. This study aimed to explore oncologists’ attitudes towards FT, the barriers they face in managing it and potential ...

Spread the love“`html The integration of artificial intelligence into healthcare has been hailed as a revolutionary step, ...

The guidelines have changed recently as new testing options have become available. Getting screened doesn’t have to be ...

But at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO), thousands of doctors and researchers rose ...

While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients to the ...

Merck is the pharmaceutical company that makes a medication called pembrolizumab (Keytruda), which is used to treat different ...

Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer ...

An analysis of cancer medicines approved in the past couple decades to treat adults with solid tumors revealed what ...

Estrella Immunopharma, Inc. ("Estrella" or the "Company"), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune ...

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic ...

Background New-onset diabetes (NOD) increases the risk of pancreatic cancer. Previous studies have mainly focused on the ...